155 related articles for article (PubMed ID: 27426105)
1. Bioavailability of curcumin and curcumin glucuronide in the central nervous system of mice after oral delivery of nano-curcumin.
Szymusiak M; Hu X; Leon Plata PA; Ciupinski P; Wang ZJ; Liu Y
Int J Pharm; 2016 Sep; 511(1):415-423. PubMed ID: 27426105
[TBL] [Abstract][Full Text] [Related]
2. Surface modification of solid lipid nanoparticles for oral delivery of curcumin: Improvement of bioavailability through enhanced cellular uptake, and lymphatic uptake.
Baek JS; Cho CW
Eur J Pharm Biopharm; 2017 Aug; 117():132-140. PubMed ID: 28412471
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of Curcumin Diethyl Disuccinate, a Prodrug of Curcumin, in Wistar Rats.
Bangphumi K; Kittiviriyakul C; Towiwat P; Rojsitthisak P; Khemawoot P
Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):777-785. PubMed ID: 26563392
[TBL] [Abstract][Full Text] [Related]
4. Metabolic and pharmacokinetic studies of curcumin, demethoxycurcumin and bisdemethoxycurcumin in mice tumor after intragastric administration of nanoparticle formulations by liquid chromatography coupled with tandem mass spectrometry.
Li R; Qiao X; Li Q; He R; Ye M; Xiang C; Lin X; Guo D
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Sep; 879(26):2751-8. PubMed ID: 21856253
[TBL] [Abstract][Full Text] [Related]
5. A combination of complexation and self-nanoemulsifying drug delivery system for enhancing oral bioavailability and anticancer efficacy of curcumin.
Shukla M; Jaiswal S; Sharma A; Srivastava PK; Arya A; Dwivedi AK; Lal J
Drug Dev Ind Pharm; 2017 May; 43(5):847-861. PubMed ID: 27648633
[TBL] [Abstract][Full Text] [Related]
6. Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production.
Ireson C; Orr S; Jones DJ; Verschoyle R; Lim CK; Luo JL; Howells L; Plummer S; Jukes R; Williams M; Steward WP; Gescher A
Cancer Res; 2001 Feb; 61(3):1058-64. PubMed ID: 11221833
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice.
Zhongfa L; Chiu M; Wang J; Chen W; Yen W; Fan-Havard P; Yee LD; Chan KK
Cancer Chemother Pharmacol; 2012 Mar; 69(3):679-89. PubMed ID: 21968952
[TBL] [Abstract][Full Text] [Related]
8. Curcumin micelles improve mitochondrial function in neuronal PC12 cells and brains of NMRI mice - Impact on bioavailability.
Hagl S; Kocher A; Schiborr C; Kolesova N; Frank J; Eckert GP
Neurochem Int; 2015 Oct; 89():234-42. PubMed ID: 26254982
[TBL] [Abstract][Full Text] [Related]
9. Curcumin attenuates opioid tolerance and dependence by inhibiting Ca2+/calmodulin-dependent protein kinase II α activity.
Hu X; Huang F; Szymusiak M; Liu Y; Wang ZJ
J Pharmacol Exp Ther; 2015 Mar; 352(3):420-8. PubMed ID: 25515789
[TBL] [Abstract][Full Text] [Related]
10. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
[TBL] [Abstract][Full Text] [Related]
11. Enhancing Curcumin Oral Bioavailability Through Nanoformulations.
Ipar VS; Dsouza A; Devarajan PV
Eur J Drug Metab Pharmacokinet; 2019 Aug; 44(4):459-480. PubMed ID: 30771095
[TBL] [Abstract][Full Text] [Related]
12. Improving the oral bioavailability of curcumin using novel organogel-based nanoemulsions.
Yu H; Huang Q
J Agric Food Chem; 2012 May; 60(21):5373-9. PubMed ID: 22506728
[TBL] [Abstract][Full Text] [Related]
13. Chemopreventive efficacy of oral curcumin: a prodrug hypothesis.
Liu G; Khanna V; Kirtane A; Grill A; Panyam J
FASEB J; 2019 Aug; 33(8):9453-9465. PubMed ID: 31136203
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of curcumin-loaded PLGA and PLGA-PEG blend nanoparticles after oral administration in rats.
Khalil NM; do Nascimento TC; Casa DM; Dalmolin LF; de Mattos AC; Hoss I; Romano MA; Mainardes RM
Colloids Surf B Biointerfaces; 2013 Jan; 101():353-60. PubMed ID: 23010041
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics, Pharmacodynamics, and PKPD Modeling of Curcumin in Regulating Antioxidant and Epigenetic Gene Expression in Healthy Human Volunteers.
Cheng D; Li W; Wang L; Lin T; Poiani G; Wassef A; Hudlikar R; Ondar P; Brunetti L; Kong AN
Mol Pharm; 2019 May; 16(5):1881-1889. PubMed ID: 30860383
[TBL] [Abstract][Full Text] [Related]
16. Safety, Tolerance, and Enhanced Efficacy of a Bioavailable Formulation of Curcumin With Fenugreek Dietary Fiber on Occupational Stress: A Randomized, Double-Blind, Placebo-Controlled Pilot Study.
Pandaran Sudheeran S; Jacob D; Natinga Mulakal J; Gopinathan Nair G; Maliakel A; Maliakel B; Kuttan R; Im K
J Clin Psychopharmacol; 2016 Jun; 36(3):236-43. PubMed ID: 27043120
[TBL] [Abstract][Full Text] [Related]
17. Curcuminoids form reactive glucuronides in vitro.
Pfeiffer E; Hoehle SI; Walch SG; Riess A; Sólyom AM; Metzler M
J Agric Food Chem; 2007 Jan; 55(2):538-44. PubMed ID: 17227090
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability of curcumin: problems and promises.
Anand P; Kunnumakkara AB; Newman RA; Aggarwal BB
Mol Pharm; 2007; 4(6):807-18. PubMed ID: 17999464
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems.
Cui J; Yu B; Zhao Y; Zhu W; Li H; Lou H; Zhai G
Int J Pharm; 2009 Apr; 371(1-2):148-55. PubMed ID: 19124065
[TBL] [Abstract][Full Text] [Related]
20. In vivo evaluation of a self-nanoemulsifying drug delivery system for curcumin.
Nazari-Vanani R; Moezi L; Heli H
Biomed Pharmacother; 2017 Apr; 88():715-720. PubMed ID: 28152481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
